In particular, several studies have demonstrated PD-relevant and progressive neuropathological (including development of insoluble α-synuclein aggregates) and behavioral features in mice28, rats29,30, and non-human primates31 following SNc-targeted AAV-driven overexpression of human mutant A53T α-synuclein. This evidence concerns the gene SNCA and Parkinson disease.